chr13-101720941-T-TAATC

Position:

• chr13-101720941-T-TAATC

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_Moderate BS1 BS2

The NM_004115.4(FGF14):​c.*1886_*1889dupGATT variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.00347 in 152,272 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).

• Frequency:
  • Genomes: 𝑓 0.0035 (0 hom., cov: 32)
  • Failed GnomAD Quality Control
• Consequence: FGF14 NM_004115.4 3_prime_UTR
• Clinical Significance: Likely benign criteria provided, single submitter B:1
• Conservation: PhyloP100: 3.78

Genes affected

FGF14 (HGNC:3671): (fibroblast growth factor 14) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. A mutation in this gene is associated with autosomal dominant cerebral ataxia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]

ENSG00000276012 (HGNC:):

ACMG classification

Verdict is Benign. Variant got -10 ACMG points.

• BP6: Variant 13-101720941-T-TAATC is Benign according to our data. Variant chr13-101720941-T-TAATC is described in ClinVar as [Likely_benign]. Clinvar id is 310859.Status of the report is criteria_provided_single_submitter, 1 stars.
• BS1: Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00347 (529/152272) while in subpopulation NFE AF= 0.00418 (284/68008). AF 95% confidence interval is 0.00378. There are 0 homozygotes in gnomad4. There are 276 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
• BS2: High AC in GnomAd4 at 529 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
FGF14	NM_004115.4	c.*1886_*1889dupGATT		3_prime_UTR_variant	5/5	ENST00000376143.5	NP_004106.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
FGF14	ENST00000376143	c.*1886_*1889dupGATT		3_prime_UTR_variant	5/5	1	NM_004115.4	ENSP00000365313.4
FGF14	ENST00000376131	c.*1886_*1889dupGATT		3_prime_UTR_variant	5/5	1		ENSP00000365301.3
ENSG00000276012	ENST00000415285.1	n.80-754_80-751dupATCA		intron_variant		3

Frequencies

GnomAD3 genomes AF: 0.00347 AC: 528 AN: 152154 Hom.: 0 Cov.: 32

Gnomad AFR AF: 0.000796

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00105

Gnomad ASJ AF: 0.0248

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00

Gnomad FIN AF: 0.00979

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.00416

Gnomad OTH AF: 0.00287

GnomAD4 exome Data not reliable, filtered out with message: AC0 AC: 0 AN: 0 Hom.: 0 Cov.: 0 AC XY: 0 AN XY: 0

GnomAD4 genome AF: 0.00347 AC: 529 AN: 152272 Hom.: 0 Cov.: 32 AF XY: 0.00371 AC XY: 276 AN XY: 74464

Gnomad4 AFR AF: 0.000794

Gnomad4 AMR AF: 0.00105

Gnomad4 ASJ AF: 0.0248

Gnomad4 EAS AF: 0.00

Gnomad4 SAS AF: 0.00

Gnomad4 FIN AF: 0.00979

Gnomad4 NFE AF: 0.00418

Gnomad4 OTH AF: 0.00284

Alfa AF: 0.00351 Hom.: 0

Bravo AF: 0.00259

ClinVar

Significance: Likely benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

Autosomal dominant cerebellar ataxia Benign:1

Likely benign, criteria provided, single submitter

clinical testing

Illumina Laboratory Services, Illumina

Jun 14, 2016

- -

Computational scores

Source: dbNSFP v4.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs559888067; hg19: chr13-102373291;